BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  Dianthus Therapeutics, Inc. Announces Closing of its Upsized $719 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

  March 13, 2026

   · 

  5 min read
• Press Releases

  Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

  March 13, 2026

   · 

  3 min read
• Press Releases

  INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

  March 13, 2026

   · 

  15 min read
• Press Releases

  Nektar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results

  March 13, 2026

   · 

  14 min read
• Press Releases

  Champions Oncology Reports Revenue of $16.6 Million

  March 13, 2026

   · 

  16 min read
• Press Releases

  ImmunoBrain to Present Topline Phase 1b Clinical Data for Immune Checkpoint Treatment in Alzheimer’s Disease at AD/PD™ 2026

  March 13, 2026

   · 

  3 min read
• Press Releases

  GRAIL Announces Retirement of CEO Bob Ragusa and Appointment of Josh Ofman, MD, MSHS, as Successor

  March 13, 2026

   · 

  4 min read
• Press Releases

  Precipio Announces Q4 and year-end 2025 Shareholder Update Call

  March 13, 2026

   · 

  4 min read
• Press Releases

  Curis to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on March 19, 2026

  March 13, 2026

   · 

  1 min read
• Press Releases

  Cellectis to Report Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026

  March 13, 2026

   · 

  1 min read